Elsevier

Atherosclerosis

Volume 90, Issue 1, September 1991, Pages 9-21
Atherosclerosis

Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia

https://doi.org/10.1016/0021-9150(91)90239-YGet rights and content

Abstract

We present the case of a 42-year-old male with familial hypercholesterolemia (FH) who had received long-term low-density lipoprotein (LDL)-apheresis before death occurred, presumably from an arrhythmia. He had been treated with double filtration plasmapheresis (DFPP) for 4 years and selective LDL adsorbent plasmapheresis (LAPP) for 2 years and 7 months. During the period of treatment (6 years and 7 months) he had received a total of 129 sessions of LDL-apheresis. Serum total cholesterol of the patient before the treatment was 638 mg/dl and during the treatment, the time-averaged values ranged from 336 mg/dl to 411 mg/dl for the first 4 years (with DFPP) and from 257 mg/dl to 364 mg/dl for the sequential 2 years and 7 months (with LAPP). Coronary angiograms were analysed for 13 segments of the coronary arteries using a digitized processing system. Analysis documented regression by identifying a reduction in percent stenosis from 34% to 20% in the proximal left circumflex artery (LCX), from 78% to 61% in the proximal right coronary artery (RCA), and from 92% to 72% in the middle RCA. In the other 10 segments analysed no significant regression and no progression were observed. The autopsy findings of the step-wise serial sections of the native coronary arteries did not record the formation of new and/or typical atheroma. In addition, a thickened intima, and an eccentric thickened wall lesion rich in collagen fiber were observed, although an accumulation of foam cells in the thickened wall lesions was found in some segments. This observation suggested scarring of the atheromatous plaque. We confirmed that LDL-apheresis performed over a period of 6 years and 7 months induced angiographic regression-,of coronary atherosclerosis in the patient with FH, and found that most of the atherosclerotic lesions were changed pathologically into sclerotic lesions rich in collagen fiber.

Reference (23)

  • SasakiH. et al.

    Reverse rinse of the second filter in double filtration plasmapheresis: when to rinse and influence on removal of cholesterol.

  • Cited by (43)

    • Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis

      2013, Transfusion and Apheresis Science
      Citation Excerpt :

      Remarkably, in the study cohort, both apheresis modalities (PA and LDL-A) resulted in a reduction of up to 68% in LDL-C and disappearance of atherosclerotic plaques, with no increase in carotid IMT in all patients. These data are consistent with previous reports [20,21]. Echocardiographic evaluations recently performed in our study demonstrated normal tricuspid aortic valves, no supravalvular changes and normal carotid orifices in all patients and grade 1/4 aortic insufficiency in 4/5 patients.

    • Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound

      2008, Clinical Lipidology: A Companion to Braunwald's Heart Disease Expert Consult: Online and Print
    • Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: The low density lipoprotein-apheresis coronary morphology and reserve trial (LACMART)

      2002, Journal of the American College of Cardiology
      Citation Excerpt :

      To our knowledge, the present study is the first one to directly evaluate the combined effect of lipid-lowering drug therapy and LDL-A on coronary plaque using IVUS in severe hypercholesterolemic patients with CAD. Regression and/or retardation of coronary atherosclerosis (15,16,18)and reduction of cardiac event (19)have proved to be the major treatment effects of LDL-A. Several possible mechanisms have been suggested for the reduction in cardiac events—for example, improvement in vascular endothelial functions (20), stabilization of plaques (21), prolongation in oxidizability of low density lipoprotein (22,23), reduction or suppression of the expression of adhesion molecules (24,25)and suppression of platelet activation (26). The present study is the first to focus on quantification of the changes occurring in atherosclerotic plaque after LDL-A therapy, and it has demonstrated marked regression of coronary plaques by measurement with IVUS.

    • Invasive Imaging Modalities and Atherosclerosis: The Role of Intravascular Ultrasound

      2009, Clinical Lipidology: A Companion to Braunwald's Heart Disease
    View all citing articles on Scopus
    View full text